Session 1 — Cardiology
-
CME Information or Content Source:Content Derived from a CME Certified Webinar in September 2022
-
Event Sponsor(s):This activity is supported by an educational grant from Bristol Myers Squibb.
-
Event Details:Program provided by Boston University (BU) and Association of Community Cancer Centers (ACCC)
Speakers
Avirup Guha, MD, MBBS, MPH, FACC, FICOS, RPVI
Director of Cardio-Oncology, Cardio-Oncology Program, Georgia Cancer Center
Assistant Professor of Medicine, Division of Cardiovascular Disease, Augusta University
An expert in cardiovascular epidemiology pertaining to cardio-oncology
Laura Wood, RN, MSN OCN
Oncology Nurse Specialist, Medina, Ohio
Learning Objectives
At the end of this educational program, participants should be able to:
- Apply evidence-based practices for the monitoring and management of immune-related adverse events (irAE) in patients receiving cancer immunotherapies
- Improve coordination and communication with non-oncology specialists and with patients/caregivers to manage irAE in patients receiving cancer immunotherapies
- Review strategies for providing equitable care for underserved patients receiving cancer immunotherapies
Click here to learn about remaining Project ECHO sessions or to view other available recordings.
